Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer

Nitya Nair; Ed Lemmens; Amanda Enstrom; Shih-Yu Chen; Serena Chang; Dung Le; Elizabeth M Jaffee; Holden Maecker; Aimee L Murphy; Dirk G Brockstedt; Chan Whiting

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer

【24h】

Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer

机译：转移性胰腺癌患者IIa期的长期存活者和免疫生物标记分析，GVAX胰腺和crs-207免疫疗法的随机研究

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer 》 |2015年第s2期| 共页
作者
Nitya Nair; Ed Lemmens; Amanda Enstrom; Shih-Yu Chen; Serena Chang; Dung Le; Elizabeth M Jaffee; Holden Maecker; Aimee L Murphy; Dirk G Brockstedt; Chan Whiting;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR) [J] . Dung T Le, Todd S Crocenzi, Jennifer N Urum, Journal for ImmunoTherapy of Cancer . 2015 ,第S2期

机译：GVAX胰腺（含环磷酰胺）和CRS-207联合或不联合nivolumab在先前治疗过的转移性胰腺腺癌（STELLAR）患者中的安全性，疗效和免疫应答的II期随机研究
2. A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study) [J] . Andrea Wang-Gillam, Vincent Picozzi, Todd Crocenzi, Journal for ImmunoTherapy of Cancer . 2014 ,第S3期

机译：GVAX胰腺疫苗和CRS-207与化学疗法和CRS-207相比单独在具有先前治疗的转移性胰腺腺癌（Eclipse研究）中的CRS-207（Eclipse研究）相比的疗法，随机多中心研究
3. Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study) [J] . Le Dung T., Picozzi Vincent J., Ko Andrew H., Clinical cancer research: an official journal of the American Association for Cancer Research . 2019 ,第18期

机译：IIB的结果，随机化，多中心研究GVAX胰腺和CRS-207与具有先前治疗的转移性胰腺腺癌的成人化疗（Eclipse研究）相比
4. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
5. Comparative Analysis on Innate Immune System Function in Metastatic Breast, Colorectal, and Prostate Cancer Patients with Circulating Tumor Cells [D] . Santos, Mark Anthony Francisco. 2014

机译：转移性乳腺癌，结直肠癌和前列腺癌患者循环肿瘤细胞先天免疫系统功能的比较分析
6. Long term survivors and immune biomarker analysis of Phase IIa randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer [O] . Nitya Nair, Ed Lemmens, Amanda Enstrom, 2015

机译：转移性胰腺癌患者IIa期的长期存活者和免疫生物标志物分析GVAX胰腺和crs-207免疫疗法的随机研究
7. Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer [O] . 2015

机译：转移性胰腺癌患者IIa期的长期存活者和免疫生物标志物分析，GVAX胰腺和crs-207免疫疗法的随机研究

Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer

著录项

相似文献

相关主题

期刊订阅